Table 5.
Characteristics | Adjusted HR (95% CI) | Interaction P Value | |
---|---|---|---|
Women | Men | ||
Surgery | |||
CABG | Reference | Reference | 0.03 |
CABG+single valvea | 1.39 (1.27–1.53) | 1.43 (1.35–1.53) | |
CABG+multiple valvesa | 1.92 (1.53–2.42) | 1.64 (1.39–1.94) | |
Single valvea | 1.23 (1.12–1.35) | 1.34 (1.24–1.44) | |
Multiple valvesa | 1.24 (1.03–1.49) | 1.73 (1.47–2.03) | |
Age group, y | |||
40–64 | Reference | Reference | 0.001 |
65–74 | 1.71 (1.54–1.89) | 1.74 (1.64–1.85) | |
75–84 | 2.78 (2.52–3.07) | 3.28 (3.09–3.49) | |
≥85 | 4.24 (3.66–4.91) | 5.31 (4.79–5.9) | |
Recent MI | 1.30 (1.21–1.40) | 1.05 (1.00–1.11) | <0.001 |
Remote MI | 1.27 (1.17–1.38) | 1.14 (1.08–1.20) | 0.03 |
Previous PCI | 1.06 (0.96–1.17) | 0.93 (0.87–0.99) | 0.04 |
COPD/asthma | 1.26 (1.18–1.35) | 1.37 (1.31–1.43) | 0.05 |
Depression | 1.20 (1.00–1.44) | 1.52 (1.32–1.75) | 0.04 |
CABG indicates coronary artery bypass grafting; COPD, chronic obstructive pulmonary disease; HR, hazard ratio; MI, myocardial infarction; PCI, percutaneous coronary intervention.
Mitral, aortic, or tricuspid valve surgery.